HAE vs NBIX
Haemonetics vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | HAE | NBIX |
|---|---|---|
| AI Score | 47 | 63 |
| Price | — | — |
| P/E Ratio | 38.17× | 25.47× |
| ROE | 0.1% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.6% | 1.0% |
| Debt / Equity | 1.54× | 0.12× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 61.6 | 45.1 |
| Beta | 0.521 | 0.386 |
| Expected Upside | — | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
HAE Full Analysis
NBIX Full Analysis